The Clinical Significance of HER2+ Breast Cancer and Opportunities for Improved Outcomes

Dana-Farber Cancer Institute
H

Antibody Drug Conjugates Highlights - mBC Series

By Dana-Farber Cancer Institute FEATURING Harold Burstein
By Dana-Farber Cancer Institute FEATURING Harold Burstein
235 views
February 15, 2024
0 Comments
Login to view comments. Click here to Login
13:28
Stanford Medicine

ADCs in HR+ Advanced/Metastatic BC

Feat. M. Dolezal
20:46
Miami Cancer Institute Precision Oncology Symposium

HER2 Targeted Treatments in Lower BC Expression Ranges

Feat. I. Krop
21:20
Dana-Farber Cancer Institute

Older Adults With Breast Cancer: Research Updates

Feat. R. Freedman
23:07
Keck School of Medicine of USC

2024 Updates on the Future of ADCs in Breast Cancer

Feat. C. Geyer
20:31
OncoAlert

HER2+ mBC: Year-in-Review Including DESTINY Breast-03 & HER2CLIM…

Feat. S. Graff
05:02
Total Health

CNS Metastasis in Breast Cancer: Surgery & Radiation Considerati…

Feat. C. Santa-Maria
12:54
Total Health

Antibody Drug Conjugates: Highlights in Breast Cancer

Feat. K. Kalinsky
19:34
Keck School of Medicine of USC

Breast Cancer Oligometastases and Beyond

Feat. S. Chmura
25:25
Alessia Pellerino

Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addres…

29:40
Insights from 2023 SABCS

Year in Review: Metastatic Breast Cancer

Feat. M. Mac Gregor
03:28
Total Health

62 y/o With HER2+ mBC Who Underwent 2L TDXd Therapy: Case Presentati…

Feat. P. Sharma, M. Telli, K. Kalinsky
21:31
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Summary: "Community Oncologists Highlights&quo…

Feat. S. Tolaney, H. Rugo
12:07
Sara Tolaney

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
13:05
V.K. Gadi

Key Updates and Insights on HER2+ Breast Cancer

19:30
Elisa Agostinetto

The Evolving Landscape of Treatment Options in HER2+ mBC

04:04
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Updated Survival Data in DESTINY-Breast03…

Feat. E. Hamilton
10:31
Sarah Premji

Treatment Selection in 2L for HER2+ MBC: Updated Guidelines, Safety …

21:01
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cance…

Feat. S. Tolaney, H. Rugo
11:57
V.K. Gadi

Clinical Guidance on the Management and Monitoring of T-DXd-Related …

10:09
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatmen…

Feat. H. Rugo
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
17:48
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Frontiers in Breast Cancer Brain Metastasis: ADC Effectiveness in th…

Feat. S. Modi
20:19
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Chemoprevention in Brain Mets: Breast Cancer Perspective

Feat. A. Zimmer